Glucosalino Isotónico B. Braun

Glucosalino Isotónico B. Braun is an injectable isotonic solution that combines sodium chloride and glucose monohydrate in a sterile liquid form for intravenous administration. The product is supplied as a solution for injection, marketed in the European Union, and requires a prescription. It is designed to provide fluid, electrolyte, and energy support in clinical settings. It may be used when volume expansion or correction of electrolyte imbalances is clinically indicated.

Glucosalino Isotónico B. Braun is indicated for clinical situations that require intravenous fluid and electrolyte replacement.

- Fluid replacement in patients with dehydration or blood loss. - Maintenance of electrolyte balance during surgery or intensive care. - Management of hypoglycemia when glucose supplementation is needed. - Component of parenteral nutrition regimens to provide carbohydrate calories. - Support of plasma volume in trauma or burn patients. - Adjunct therapy for patients receiving diuretics who require sodium chloride supplementation.

Adverse reactions to Glucosalino Isotónico B. Braun are generally infrequent, but they are documented in clinical practice.

Common: - Mild local irritation at the infusion site. - Transient increase in blood glucose levels. - Slight electrolyte disturbances such as hypernatremia.

Serious: - Severe allergic reaction (anaphylaxis) with rash, wheezing, or hypotension. - Fluid overload leading to pulmonary edema. - Hyperglycemia requiring medical intervention.

When prescribing or administering Glucosalino Isotónico B. Braun, clinicians should consider several safety precautions to minimize risk.

- Assess patient’s fluid status and electrolyte levels before infusion. - Use caution in patients with congestive heart failure or renal impairment. - Monitor blood glucose closely in diabetic or hyperglycemic individuals. - Avoid rapid infusion rates that may cause circulatory overload. - Verify compatibility with other intravenous solutions before mixing. - Discontinue if signs of allergic reaction appear. - Document volume administered in the patient’s medical record.

Glucosalino Isotónico B. Braun may interact with other intravenous agents; awareness of these interactions helps ensure safe co‑administration.

Avoid: - Co‑administration with hypertonic saline solutions, which can cause excessive sodium load. - Simultaneous infusion of high‑dose insulin without glucose monitoring, increasing risk of hypoglycemia.

Use with caution: - Concurrent use of diuretics that may alter sodium balance; monitor electrolytes. - Administration alongside blood products; ensure compatible infusion rates. - Use with caution in patients receiving corticosteroids, as they may affect glucose metabolism.